CDC study finds RSV vaccines protect older adults from hospitalization
The Centers for Disease Control and Prevention Sept. 4 published a study in JAMA which found older adults who receive a respiratory syncytial virus vaccine are 75% less likely to be hospitalized from RSV compared to those who don’t. The CDC last month updated RSV vaccine guidance for adults 60 and older, recommending those aged 60-74 at risk for RSV and all aged 75 and older receive one dose of the GSK, Pfizer or Moderna vaccine. Those who previously received a dosage should not seek another.
Related News Articles
Headline
The AHA's Advancing Health podcast recently celebrated the end of 2024 by releasing highlights from some of its most popular episodes of the year. The roundup…
Perspective
The arrival of the holiday season and the coming New Year remind us of the swift passage of time. But they also demonstrate the timelessness of human kindness.…
Headline
Christine McGuire Chloros, program manager for ChristianaCare's Care for the Caregiver initiative, discusses how the health system has grown its health care…
Chairperson's File
In October 1863, in the middle of the Civil War, President Abraham Lincoln decreed that Thanksgiving be held across the U.S. to “heal the wounds of the nation…
Headline
The Centers for Disease Control and Prevention May 29 published a blog co-authored by AHA, the National Institute for Occupational Safety and Health and the…
Blog
Our health may be the most personal and important thing we have. It determines how we feel when we wake up in the morning, how we relate to our families and…